Cardiology and circulatory sciences (including cardiovascular disease)

This subclass comprises research and experimental development in cardiology and circulatory sciences (including cardiovascular disease).

Parent Category

L

Loewen, Peter

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; Population health interventions; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making

O

O'Neil, Michael

Faculty of Medicine

Faculty (non-G+PS member)

Cardiology and circulatory sciences (including cardiovascular disease); ketamine; , ketamine

T

Turgeon, Ricky

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Health care effectiveness and outcomes; Knowledge translation and implementation science in health; Heart failure pharmacotherapy; Acute coronary syndromes / myocardial infarction; Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy); Cardiovascular safety of medications; Drug Effectiveness; Evidence-based practice; Shared decision making; Point-of-care decision aids / decision support tools; Knowledge translation / implementation; Risk calculators / clinical prediction tools; Pharmacist scope of practice; Heart failure pharmacotherapy, Acute coronary syndromes / myocardial infarction, Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy), Cardiovascular safety of medications, Drug effectiveness, Evidence-based practice, Shared decision making, Point-of-care decision aids / decision support tools, Knowledge translation / implementation, Risk calculators / clinical prediction tools, Pharmacist scope of practice

W

Wang, Ying

Department of Pathology & Laboratory Medicine, Faculty of Medicine

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Cell differentiation, proliferation and death; Drug discovery, design and delivery; atherosclerosis; Diabetic cardiomyopathy; Vascular biology; Spatial 'Omics'; Drug repurposing and therapeutic design; Disease modeling; Digital Pathology; Atherosclerosis, Diabetic cardiomyopathy, Vascular biology, Spatial 'Omics', Drug repurposing and therapeutic design, Disease modeling, Digital pathology

Academic Units

French Name

Cardiologie et sciences circulatoires (y compris les maladies cardiovasculaires)

French Description

Cette sous-classe comprend la recherche et le développement expérimental en cardiologie et sciences circulatoires (y compris les maladies cardiovasculaires).